• 2025
  Suspène R, Caval V, Khalfi P, Pitré E, Marchio A, Pineau P, Vartanian JP, Cobalt chloride-mimicked hepatocyte cell hypoxia induces TREX1 leading to Hepatitis B virus restriction., J Infect Dis 2025 Jan; (): .
• 2023
  Traboulsi T*, Sart S*, Baroud C, Dejean A and Cossec J-C, Generation of embryo-like structures from mouse embryonic stem cells treated with a chemical inhibitor of SUMOylation and cultured in microdroplets, STAR Protoc . 2023 Sep 17;4(4):102573.
• 2023
  Jack-Christophe Cossec* , Tatiana Traboulsi* , Sébastien Sart* , Yann Loe-Mie , Manuel Guthmann , Ivo A Hendriks , Ilan Theurillat , Michael L Nielsen , Maria-Elena Torres-Padilla , Charles N Baroud , Anne Dejean , Transient suppression of SUMOylation in embryonic stem cells generates embryo-like structures, Cell Rep . 2023 Apr 15;42(4):112380. doi: 10.1016/j.celrep.2023.112380.
• 2022
  Sitbounlang P, Deharo E, Latthaphasavang V, Marchio A, Soukhsakhone C, Soinxay V, Mayxay M, Steenkeste N, Vincelot P, Bertani S, Palamy S, Paboriboune P, Pineau P, , Estimating the burden of hepatitis B virus infection in Laos between 2020 and 2021: A cross-sectional seroprevalence survey., EClinicalMedicine 2022 Oct; 52(): 101582.
• 2022
  Khalfi P, Suspène R, Caval V, Thiers V, Beauclair G, Marchio A, Bekondi C, Amougou Atsama M, Camengo-Police SM, Noah Noah D, Njouom R, Blanc H, Vallet T, Vignuzzi M, Pineau P, Vartanian JP, APOBEC3C S188I Polymorphism Enhances Context-Specific Editing of Hepatitis B Virus Genome., J Infect Dis 2022 Sep; 226(5): 891-895.
• 2022
  Moussavou-Boundzanga P, Itoudi Bignoumba PE, Mouinga-Ondeme A, Iroungou BA, Bivigou-Mboumba B, Marchio A, Saibou M, Moussavou Kombila JB, Pineau P, , Drastic sex-dependent etiological distribution in severe liver diseases from Gabon., Front Oncol 2022 ; 12(): 907554.
• 2021
  Marchio A, Batejat C, Vanhomwegen J, Feher M, Grassin Q, Chazal M, Raulin O, Farges-Berth A, Reibel F, Estève V, Dejean A, Jouvenet N, Manuguerra JC, Pineau P, , ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads., Arch Virol 2021 Sep; 166(9): 2529-2540.
• 2021
  de Melo GD, Lazarini F, Larrous F, Feige L, Kornobis E, Levallois S, Marchio A, Kergoat L, Hardy D, Cokelaer T, Pineau P, Lecuit M, Lledo PM, Changeux JP, Bourhy H, , Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin., EMBO Mol Med 2021 Aug; 13(8): e14122.
• 2021
  Cerapio JP, Marchio A, Cano L, López I, Fournié JF, Régnault B, Casavilca-Zambrano S, Ruiz E, Dejean A, Bertani S and Pineau P, Global DNA hypermethylation pattern and unique gene expression signature in liver cancer from patients with Indigenous American ancestry, Oncotarget. 2021; 12:475-492.
• 2020
  Agarwal N, Taberner FJ, Rangel Rojas D, Moroni M, Omberbasic D, Njoo C, Andrieux A, Gupta P, Bali KK, Herpel E, Faghihi F, Fleming T, Dejean A, Lechner SG, Nawroth PP, Lewin GR, Kuner R, SUMOylation of Enzymes and Ion Channels in Sensory Neurons Protects against Metabolic Dysfunction, Neuropathy, and Sensory Loss in Diabetes., Neuron 2020 09; 107(6): 1141-1159.e7.
• 2020
  López I, Chalatsi E, Ellenbroek SIJ, Andrieux A, Roux PF, Cerapio JP, Jouvion G, van Rheenen J, Seeler JS, Dejean A, , An unanticipated tumor-suppressive role of the SUMO pathway in the intestine unveiled by Ubc9 haploinsufficiency., Oncogene 2020 Sep; (): .
• 2020
  Theurillat I, Hendriks IA, Cossec JC, Andrieux A, Nielsen ML, Dejean A, , Extensive SUMO Modification of Repressive Chromatin Factors Distinguishes Pluripotent from Somatic Cells., Cell Rep 2020 09; 32(11): 108146.
• 2020
  Wang X, Ni L, Wan S, Zhao X, Ding X, Dejean A, Dong C, Febrile Temperature Critically Controls the Differentiation and Pathogenicity of T Helper 17 Cells, Immunity 2020 02; 52(2): 328-341.e5.
• 2018
  Cossec JC*, Theurillat I*, Chica C, Bua Aguin S, Gaume X, Andrieux A, Iturbide A, Jouvion G, Li H, Bossis G, Seeler J-S, Torres-Padilla ME, Dejean A, SUMO safeguards somatic and pluripotent cell identities by enforcing distinct chromatin states, Cell Stem Cell. 2018 Nov 1;23(5):742-757.e8. doi: 10.1016/j.stem.2018.10.001.
• 2018
  Marchio A, Cerapio JP, Ruiz E, Cano L, Casavilca S, Terris B, Deharo E, Dejean A, Bertani S, Pineau P, Early-onset liver cancer in South America associates with low hepatitis B virus DNA burden, Sci Rep 2018 Aug;8(1):12031.
• 2017
  Lapaquette P, Fritah S, Lhocine N, Andrieux A, Nigro G, Mounier J, Sansonetti P, Dejean A, entry unveils a calcium/calpain-dependent mechanism for inhibiting sumoylation, Elife 2017 12;6.
• 2017
  Wang A, Ding X, Demarque M, Liu X, Pan D, Xin H, Zhong B, Wang X, Dejean A, Jin W, Dong C, Is Required for Positive Selection and Late-Stage Maturation of Thymocytes, J. Immunol. 2017 05;198(9):3461-3470.
• 2017
  Seeler JS, Dejean A, SUMO and the robustness of cancer, Nat. Rev. Cancer 2017 01;.
• 2016
  Ding X, Wang A, Ma X, Demarque M, Jin W, Xin H, Dejean A, Dong C, Protein SUMOylation Is Required for Regulatory T Cell Expansion and Function, Cell Rep 2016 Jul;16(4):1055-66.
• 2015
  Decque A, Joffre O, Magalhaes JG, Cossec JC, Blecher-Gonen R, Lapaquette P, Silvin A, Manel N, Joubert PE, Seeler JS, Albert ML, Amit I, Amigorena S, Dejean A, Sumoylation coordinates the repression of inflammatory and anti-viral gene-expression programs during innate sensing, Nat. Immunol. 2016 Feb;17(2):140-9.
• 2015
  Rebbani K, Marchio A, Ezzikouri S, Afifi R, Kandil M, Bahri O, Triki H, Essaid El Feydi A, Dejean A, Benjelloun S, Pineau P, TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma, Mol. Cancer 2015;14(1):74.
• 2014
  Marchio A, Bertani S, Rojas Rojas T, Doimi F, Terris B, Deharo E, Dejean A, Ruiz E, Pineau P, A peculiar mutation spectrum emerging from young peruvian patients with hepatocellular carcinoma, PLoS ONE 2014;9(12):e114912.
• 2014
  Puvvula PK, Desetty RD, Pineau P, Marchio A, Moon A, Dejean A, Bischof O, Long noncoding RNA PANDA and scaffold-attachment-factor SAFA control senescence entry and exit, Nat Commun 2014 Nov;5:5323.
• 2014
  Fritah S, Lhocine N, Golebiowski F, Mounier J, Andrieux A, Jouvion G, Hay RT, Sansonetti P, Dejean A, Sumoylation controls host anti-bacterial response to the gut invasive pathogen Shigella flexneri, EMBO Rep. 2014 Sep;15(9):965-72.
• 2014
  Sahin U, Lapaquette P, Andrieux A, Faure G, Dejean A, Sumoylation of human argonaute 2 at lysine-402 regulates its stability, PLoS ONE 2014;9(7):e102957.
• 2014
  Rebbani K, Ezzikouri S, Marchio A, Ababou M, Kitab B, Dejean A, Kandil M, Pineau P, Benjelloun S, Common polymorphic effectors of immunity against hepatitis B and C modulate susceptibility to infection and spontaneous clearance in a Moroccan population, Infect. Genet. Evol. 2014 Aug;26:1-7.
• 2014
  Tanase AM, Marchio A, Dumitrascu T, Dima S, Herlea V, Oprisan G, Dejean A, Popescu I, Pineau P, Mutation spectrum of hepatocellular carcinoma from eastern-European patients betrays the impact of a complex exposome, J Expo Sci Environ Epidemiol 2015 May;25(3):256-63.
• 2013
  Neyret-Kahn H, Benhamed M, Ye T, Le Gras S, Cossec JC, Lapaquette P, Bischof O, Ouspenskaia M, Dasso M, Seeler J, Davidson I, Dejean A, Sumoylation at chromatin governs coordinated repression of a transcriptional program essential for cell growth and proliferation, Genome Res. 2013 Oct;23(10):1563-79.
• 2013
  Kalinina O, Marchio A, Urbanskii AI, Tarkova AB, Rebbani K, Granov DA, Dejean A, Generalov MI, Pineau P, Somatic changes in primary liver cancer in Russia: a pilot study, Mutat. Res. 2013 Aug;755(2):90-9.
• 2013
  Erker Y, Neyret-Kahn H, Seeler JS, Dejean A, Atfi A, Levy L, Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation, Mol. Cell. Biol. 2013 Jun;33(11):2163-77.
• 2013
  Diala I, Wagner N, Magdinier F, Shkreli M, Sirakov M, Bauwens S, Schluth-Bolard C, Simonet T, Renault VM, Ye J, Djerbi A, Pineau P, Choi J, Artandi S, Dejean A, Plateroti M, Gilson E, Telomere protection and TRF2 expression are enhanced by the canonical Wnt signalling pathway, EMBO Rep. 2013 Apr;14(4):356-63.
• 2012
  Marchio A, Akil A, Terris B, Dejean A, Pineau P, Insertion/deletion polymorphisms are convenient and reliable markers to assess chromosomal instability in human tumors, Int. J. Biol. Markers 2012 Jul-Sep;27(3):e232-40.
• 2012
  Akil A, Ezzikouri S, El Feydi AE, Benazzouz M, Afifi R, Diagne AG, Benjouad A, Dejean A, Pineau P, Benjelloun S, Associations of genetic variants in the transcriptional coactivators EP300 and PCAF with hepatocellular carcinoma, Cancer Epidemiol 2012 Oct;36(5):e300-5.
• 2012
  Martin N, Dejean A, Bischof O, [A new player in PML-mediated cellular senescence: TBX2 gets into the loop], Med Sci (Paris) 2012 Mar;28(3):248-50.
• 2012
  Benhamed M, Herbig U, Ye T, Dejean A, Bischof O, Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells, Nat. Cell Biol. 2012 Mar;14(3):266-75.
• 2011
  Martin N, Benhamed M, Nacerddine K, Demarque MD, van Lohuizen M, Dejean A, Bischof O, Physical and functional interaction between PML and TBX2 in the establishment of cellular senescence, EMBO J. 2012 Jan;31(1):95-109.
• 2011
  Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS, Alder H, Liu CG, Dejean A, Croce CM, p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2, J. Exp. Med. 2011 May;208(5):875-83.
• 2011
  Suspène R, Aynaud MM, Guétard D, Henry M, Eckhoff G, Marchio A, Pineau P, Dejean A, Vartanian JP, Wain-Hobson S, Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism, Proc. Natl. Acad. Sci. U.S.A. 2011 Mar;108(12):4858-63.
• 2011
  Bahri O, Ezzikouri S, Alaya-Bouafif NB, Iguer F, Feydi AE, Mestiri H, Benazzouz M, Khalfallah T, Afifi R, Elkihal L, Berkane S, Marchio A, Debzi N, Dejean A, Pineau P, Triki H, Benjelloun S, First multicenter study for risk factors for hepatocellular carcinoma development in North Africa, World J Hepatol 2011 Jan;3(1):24-30.
• 2010
  Demarque MD, Nacerddine K, Neyret-Kahn H, Andrieux A, Danenberg E, Jouvion G, Bomme P, Hamard G, Romagnolo B, Terris B, Cumano A, Barker N, Clevers H, Dejean A, Sumoylation by Ubc9 regulates the stem cell compartment and structure and function of the intestinal epithelium in mice, Gastroenterology 2011 Jan;140(1):286-96.
• 2010
  Vartanian JP, Henry M, Marchio A, Suspène R, Aynaud MM, Guétard D, Cervantes-Gonzalez M, Battiston C, Mazzaferro V, Pineau P, Dejean A, Wain-Hobson S, Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis, PLoS Pathog. 2010 May;6(5):e1000928.
• 2010
  Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, Baffa R, Aqeilan R, Iorio MV, Taccioli C, Garzon R, Di Leva G, Fabbri M, Catozzi M, Previati M, Ambs S, Palumbo T, Garofalo M, Veronese A, Bottoni A, Gasparini P, Harris CC, Visone R, Pekarsky Y, de la Chapelle A, Bloomston M, Dillhoff M, Rassenti LZ, Kipps TJ, Huebner K, Pichiorri F, Lenze D, Cairo S, Buendia MA, Pineau P, Dejean A, Zanesi N, Rossi S, Calin GA, Liu CG, Palatini J, Negrini M, Vecchione A, Rosenberg A, Croce CM, Reprogramming of miRNA networks in cancer and leukemia, Genome Res. 2010 May;20(5):589-99.
• 2010
  Ribet D, Hamon M, Gouin E, Nahori MA, Impens F, Neyret-Kahn H, Gevaert K, Vandekerckhove J, Dejean A, Cossart P, Listeria monocytogenes impairs SUMOylation for efficient infection, Nature 2010 Apr;464(7292):1192-5.
• 2010
  Janer A, Werner A, Takahashi-Fujigasaki J, Daret A, Fujigasaki H, Takada K, Duyckaerts C, Brice A, Dejean A, Sittler A, SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7, Hum. Mol. Genet. 2010 Jan;19(1):181-95.
• 2009
  Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM, Dejean A, miR-221 overexpression contributes to liver tumorigenesis, Proc. Natl. Acad. Sci. U.S.A. 2010 Jan;107(1):264-9.
• 2009
  Martin N, Schwamborn K, Schreiber V, Werner A, Guillier C, Zhang XD, Bischof O, Seeler JS, Dejean A, PARP-1 transcriptional activity is regulated by sumoylation upon heat shock, EMBO J. 2009 Nov;28(22):3534-48.
• 2009
  Fernandez AF, Rosales C, Lopez-Nieva P, Graña O, Ballestar E, Ropero S, Espada J, Melo SA, Lujambio A, Fraga MF, Pino I, Javierre B, Carmona FJ, Acquadro F, Steenbergen RD, Snijders PJ, Meijer CJ, Pineau P, Dejean A, Lloveras B, Capella G, Quer J, Buti M, Esteban JI, Allende H, Rodriguez-Frias F, Castellsague X, Minarovits J, Ponce J, Capello D, Gaidano G, Cigudosa JC, Gomez-Lopez G, Pisano DG, Valencia A, Piris MA, Bosch FX, Cahir-McFarland E, Kieff E, Esteller M, The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer, Genome Res. 2009 Mar;19(3):438-51.
• 2009
  Bischof O, Dejean A, Pineau P, [A review of cellular senescence: friend or foe of tumorigenesis?], Med Sci (Paris) 2009 Feb;25(2):153-60.
• 2008
  Pineau P, Marchio A, Battiston C, Cordina E, Russo A, Terris B, Qin LX, Turlin B, Tang ZY, Mazzaferro V, Dejean A, Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin exposure, Mutat. Res. 2008 May;653(1-2):6-13.
• 2008
  Martin N, Schwamborn K, Urlaub H, Gan B, Guan JL, Dejean A, Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activity, Mol. Cell. Biol. 2008 Apr;28(8):2771-81.
• 2008
  Ezzikouri S, Chemin I, Chafik A, Wakrim L, Nourlil J, Malki AE, Marchio A, Dejean A, Hassar M, Trepo C, Pineau P, Benjelloun S, Genotype determination in Moroccan hepatitis B chronic carriers, Infect. Genet. Evol. 2008 May;8(3):306-12.
• 2007
  Pineau P, Ezzikouri S, Marchio A, Benazzouz M, Cordina E, Afifi R, Elkihal L, Khalfallah MT, Mestiri H, Tebbal S, Berkane S, Debzi N, Triki H, Dejean A, Iguer F, Bahri O, Essaid El Feydi AE, Benjelloun S, Genomic stability prevails in North-African hepatocellular carcinomas, Dig Liver Dis 2007 Jul;39(7):671-7.
• 2007
  Bischof O, Dejean A, SUMO is growing senescent, Cell Cycle 2007 Mar;6(6):677-81.
• 2007
  Carter S, Bischof O, Dejean A, Vousden KH, C-terminal modifications regulate MDM2 dissociation and nuclear export of p53, Nat. Cell Biol. 2007 Apr;9(4):428-35.
• 2007
  Stankovic-Valentin N, Deltour S, Seeler J, Pinte S, Vergoten G, Guérardel C, Dejean A, Leprince D, An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity, Mol. Cell. Biol. 2007 Apr;27(7):2661-75.
• 2007
  Renard CA, Labalette C, Armengol C, Cougot D, Wei Y, Cairo S, Pineau P, Neuveut C, de Reyniès A, Dejean A, Perret C, Buendia MA, Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer, Cancer Res. 2007 Feb;67(3):901-10.
• 2007
  Xhemalce B, Riising EM, Baumann P, Dejean A, Arcangioli B, Seeler JS, Role of SUMO in the dynamics of telomere maintenance in fission yeast, Proc. Natl. Acad. Sci. U.S.A. 2007 Jan;104(3):893-8.
• 2007
  Seeler JS, Bischof O, Nacerddine K, Dejean A, SUMO, the three Rs and cancer, Curr. Top. Microbiol. Immunol. 2007;313:49-71.
• 2006
  Kumar PP, Bischof O, Purbey PK, Notani D, Urlaub H, Dejean A, Galande S, Functional interaction between PML and SATB1 regulates chromatin-loop architecture and transcription of the MHC class I locus, Nat. Cell Biol. 2007 Jan;9(1):45-56.
• 2006
  Di Benedetto M, Pineau P, Nouet S, Berhouet S, Seitz I, Louis S, Dejean A, Couraud PO, Strosberg AD, Stoppa-Lyonnet D, Nahmias C, Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma, Mol. Cell. Endocrinol. 2006 Jun;252(1-2):207-15.
• 2005
  Nacerddine K, Lehembre F, Bhaumik M, Artus J, Cohen-Tannoudji M, Babinet C, Pandolfi PP, Dejean A, The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice, Dev. Cell 2005 Dec;9(6):769-79.
• 2005
  van den Akker E, Ano S, Shih HM, Wang LC, Pironin M, Palvimo JJ, Kotaja N, Kirsh O, Dejean A, Ghysdael J, FLI-1 functionally interacts with PIASxalpha, a member of the PIAS E3 SUMO ligase family, J. Biol. Chem. 2005 Nov;280(45):38035-46.
• 2005
  Artus J, Vandormael-Pournin S, Frödin M, Nacerddine K, Babinet C, Cohen-Tannoudji M, Impaired mitotic progression and preimplantation lethality in mice lacking OMCG1, a new evolutionarily conserved nuclear protein, Mol. Cell. Biol. 2005 Jul;25(14):6289-302.
• 2004
  Pineau P, Henry M, Suspène R, Marchio A, Dettai A, Debruyne R, Petit T, Lécu A, Moisson P, Dejean A, Wain-Hobson S, Vartanian JP, A universal primer set for PCR amplification of nuclear histone H4 genes from all animal species, Mol. Biol. Evol. 2005 Mar;22(3):582-8.
• 2004
  Chauchereau A, Mathieu M, de Saintignon J, Ferreira R, Pritchard LL, Mishal Z, Dejean A, Harel-Bellan A, HDAC4 mediates transcriptional repression by the acute promyelocytic leukaemia-associated protein PLZF, Oncogene 2004 Nov;23(54):8777-84.
• 2004
  Xhemalce B, Seeler JS, Thon G, Dejean A, Arcangioli B, Role of the fission yeast SUMO E3 ligase Pli1p in centromere and telomere maintenance, EMBO J. 2004 Oct;23(19):3844-53.
• 2003
  Poirier K, Chalas C, Tissier F, Couvert P, Mallet V, Carrié A, Marchio A, Sarli D, Gicquel C, Chaussade S, Beljord C, Chelly J, Kerjean A, Terris B, Loss of parental-specific methylation at the IGF2 locus in human hepatocellular carcinoma, J. Pathol. 2003 Nov;201(3):473-9.
• 2003
  Tallec LP, Kirsh O, Lecomte MC, Viengchareun S, Zennaro MC, Dejean A, Lombès M, Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification, Mol. Endocrinol. 2003 Dec;17(12):2529-42.
• 2003
  Seeler JS, Dejean A, Nuclear and unclear functions of SUMO, Nat. Rev. Mol. Cell Biol. 2003 Sep;4(9):690-9.
• 2003
  Pineau P, Marchio A, Cordina E, Tiollais P, Dejean A, Homozygous deletions scanning in tumor cell lines detects previously unsuspected loci, Int. J. Cancer 2003 Aug;106(2):216-23.
• 2003
  Pineau P, Marchio A, Nagamori S, Seki S, Tiollais P, Dejean A, Homozygous deletion scanning in hepatobiliary tumor cell lines reveals alternative pathways for liver carcinogenesis, Hepatology 2003 Apr;37(4):852-61.
• 2003
  Liao C, Zhao MJ, Zhao J, Song H, Pineau P, Marchio A, Dejean A, Tiollais P, Wang HY, Li TP, Mutation analysis of novel human liver-related putative tumor suppressor gene in hepatocellular carcinoma, World J. Gastroenterol. 2003 Jan;9(1):89-93.
• 2002
  Muchardt C, Guilleme M, Seeler JS, Trouche D, Dejean A, Yaniv M, Coordinated methyl and RNA binding is required for heterochromatin localization of mammalian HP1alpha, EMBO Rep. 2002 Oct;3(10):975-81.
• 2002
  Bischof O, Kirsh O, Pearson M, Itahana K, Pelicci PG, Dejean A, Deconstructing PML-induced premature senescence, EMBO J. 2002 Jul;21(13):3358-69.
• 2002
  Kirsh O, Seeler JS, Pichler A, Gast A, Müller S, Miska E, Mathieu M, Harel-Bellan A, Kouzarides T, Melchior F, Dejean A, The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase, EMBO J. 2002 Jun;21(11):2682-91.
• 2002
  Pichler A, Gast A, Seeler JS, Dejean A, Melchior F, The nucleoporin RanBP2 has SUMO1 E3 ligase activity, Cell 2002 Jan;108(1):109-20.
• 2001
  Seeler JS, Dejean A, SUMO: of branched proteins and nuclear bodies, Oncogene 2001 Oct;20(49):7243-9.
• 2001
  Marchio A, Terris B, Meddeb M, Pineau P, Duverger A, Tiollais P, Bernheim A, Dejean A, Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation, MP, Mol. Pathol. 2001 Aug;54(4):270-4.
• 2001
  Seeler JS, Marchio A, Losson R, Desterro JM, Hay RT, Chambon P, Dejean A, Common properties of nuclear body protein SP100 and TIF1alpha chromatin factor: role of SUMO modification, Mol. Cell. Biol. 2001 May;21(10):3314-24.
• 2001
  Lehembre F, Müller S, Pandolfi PP, Dejean A, Regulation of Pax3 transcriptional activity by SUMO-1-modified PML, Oncogene 2001 Jan;20(1):1-9.
• 2000
  Marchio A, Pineau P, Meddeb M, Terris B, Tiollais P, Bernheim A, Dejean A, Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients, Oncogene 2000 Aug;19(33):3733-8.
• 2000
  Zhong S, Müller S, Ronchetti S, Freemont PS, Dejean A, Pandolfi PP, Role of SUMO-1-modified PML in nuclear body formation, Blood 2000 May;95(9):2748-52.
• 2000
  Muller S, Berger M, Lehembre F, Seeler JS, Haupt Y, Dejean A, c-Jun and p53 activity is modulated by SUMO-1 modification, J. Biol. Chem. 2000 May;275(18):13321-9.
• 2000
  Pineau P, Meddeb M, Raselli R, Qin LX, Terris B, Tang ZY, Tiollais P, Mazzaferro V, Dejean A, Effect of TT virus infection on hepatocellular carcinoma development: results of a Euro-Asian survey, J. Infect. Dis. 2000 Mar;181(3):1138-42.
• 2000
  Lehembre F, Badenhorst P, Müller S, Travers A, Schweisguth F, Dejean A, Covalent modification of the transcriptional repressor tramtrack by the ubiquitin-related protein Smt3 in Drosophila flies, Mol. Cell. Biol. 2000 Feb;20(3):1072-82.
• 1999
  Terris B, Pineau P, Bregeaud L, Valla D, Belghiti J, Tiollais P, Degott C, Dejean A, Close correlation between beta-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas, Oncogene 1999 Nov;18(47):6583-8.
• 1999
  Müller S, Dejean A, Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption, J. Virol. 1999 Jun;73(6):5137-43.
• 1999
  Jacob-Sebastian Seeler, Anne Dejean, The PML nuclear bodies: actors or extras?, Current Opinion in Genetics and Development, 1999, 9 (3), pp.362-367. ⟨10.1016/s0959-437x(99)80054-9⟩.
• 1999
  Pineau P, Nagai H, Prigent S, Wei Y, Gyapay G, Weissenbach J, Tiollais P, Buendia MA, Dejean A, Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma, Oncogene 1999 May;18(20):3127-34.
• 1998
  Müller S, Miller WH, Dejean A, Trivalent antimonials induce degradation of the PML-RAR oncoprotein and reorganization of the promyelocytic leukemia nuclear bodies in acute promyelocytic leukemia NB4 cells, Blood 1998 Dec;92(11):4308-16.
• 1998
  Seeler JS, Marchio A, Sitterlin D, Transy C, Dejean A, Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment, Proc. Natl. Acad. Sci. U.S.A. 1998 Jun;95(13):7316-21.
• 1998
  David G, Alland L, Hong SH, Wong CW, DePinho RA, Dejean A, Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein, Oncogene 1998 May;16(19):2549-56.
• 1998
  Pineau P, Marchio A, Mattei MG, Kim WH, Youn JK, Tiollais P, Dejean A, Extensive analysis of duplicated-inverted hepatitis B virus integrations in human hepatocellular carcinoma, J. Gen. Virol. 1998 Mar;79 ( Pt 3):591-600.
• 1998
  Müller S, Matunis MJ, Dejean A, Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus, EMBO J. 1998 Jan;17(1):61-70.
• 1997
  Hong SH, David G, Wong CW, Dejean A, Privalsky ML, SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia, Proc. Natl. Acad. Sci. U.S.A. 1997 Aug;94(17):9028-33.
• 1997
  Gongora C, David G, Pintard L, Tissot C, Hua TD, Dejean A, Mechti N, Molecular cloning of a new interferon-induced PML nuclear body-associated protein, J. Biol. Chem. 1997 Aug;272(31):19457-63.
• 1997
  Nagai H, Pineau P, Tiollais P, Buendia MA, Dejean A, Comprehensive allelotyping of human hepatocellular carcinoma, Oncogene 1997 Jun;14(24):2927-33.
• 1997
  David G, Terris B, Marchio A, Lavau C, Dejean A, The acute promyelocytic leukemia PML-RAR alpha protein induces hepatic preneoplastic and neoplastic lesions in transgenic mice, Oncogene 1997 Apr;14(13):1547-54.
• 1997
  Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A, Dejean A, Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization, Genes Chromosomes Cancer 1997 Jan;18(1):59-65.
• 1996
  Pineau P, Marchio A, Terris B, Mattei MG, Tu ZX, Tiollais P, Dejean A, A t(3;8) chromosomal translocation associated with hepatitis B virus intergration involves the carboxypeptidase N locus, J. Virol. 1996 Oct;70(10):7280-4.
• 1996
  Altabef M, Garcia M, Lavau C, Bae SC, Dejean A, Samarut J, A retrovirus carrying the promyelocyte-retinoic acid receptor PML-RARalpha fusion gene transforms haematopoietic progenitors in vitro and induces acute leukaemias, EMBO J. 1996 Jun;15(11):2707-16.
• 1996
  Lavau C, Heard JM, Danos O, Dejean A, Retroviral vectors for the transduction of the PML-RARalpha fusion product of acute promyelocytic leukemia, Exp. Hematol. 1996 Mar;24(4):544-51.
• 1995
  Carvalho T, Seeler JS, Ohman K, Jordan P, Pettersson U, Akusjärvi G, Carmo-Fonseca M, Dejean A, Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies, J. Cell Biol. 1995 Oct;131(1):45-56.
• 1995
  Lavau C, Marchio A, Fagioli M, Jansen J, Falini B, Lebon P, Grosveld F, Pandolfi PP, Pelicci PG, Dejean A, The acute promyelocytic leukaemia-associated PML gene is induced by interferon, Oncogene 1995 Sep;11(5):871-6.
• 1995
  Jansen JH, Mahfoudi A, Rambaud S, Lavau C, Wahli W, Dejean A, Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways, Proc. Natl. Acad. Sci. U.S.A. 1995 Aug;92(16):7401-5.
• 1995
  Terris B, Baldin V, Dubois S, Degott C, Flejou JF, Hénin D, Dejean A, PML nuclear bodies are general targets for inflammation and cell proliferation, Cancer Res. 1995 Apr;55(7):1590-7.
• 1993
  Doucas V, Brockes JP, Yaniv M, de Thé H, Dejean A, The PML-retinoic acid receptor alpha translocation converts the receptor from an inhibitor to a retinoic acid-dependent activator of transcription factor AP-1, Proc. Natl. Acad. Sci. U.S.A. 1993 Oct;90(20):9345-9.
• 1993
  Garcia M, de Thé H, Tiollais P, Samarut J, Dejean A, A hepatitis B virus pre-S-retinoic acid receptor beta chimera transforms erythrocytic progenitor cells in vitro, Proc. Natl. Acad. Sci. U.S.A. 1993 Jan;90(1):89-93.
• 1992
  Castaigne S, Balitrand N, de Thé H, Dejean A, Degos L, Chomienne C, A PML/retinoic acid receptor alpha fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia, Blood 1992 Jun;79(12):3110-5.
• 1991
  de Thé H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A, The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR, Cell 1991 Aug;66(4):675-84.
• 1990
  Chomienne C, Ballerini P, Balitrand N, Huang ME, Krawice I, Castaigne S, Fenaux P, Tiollais P, Dejean A, Degos L, Hugues De Thé, The retinoic acid receptor alpha gene is rearranged in retinoic acid-sensitive promyelocytic leukemias, Leukemia 1990 Dec;4(12):802-7.
• 1990
  de Thé H, Chomienne C, Lanotte M, Degos L, Dejean A, The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus, Nature 1990 Oct;347(6293):558-61.
• 1990
  Dejean A, de Thé H, Hepatitis B virus as an insertional mutagene in a human hepatocellular carcinoma, Mol. Biol. Med. 1990 Jun;7(3):213-22.
• 1990
  de Thé H, Vivanco-Ruiz MM, Tiollais P, Stunnenberg H, Dejean A, Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene, Nature 1990 Jan;343(6254):177-80.
• 1989
  de The H, Marchio A, Tiollais P, Dejean A, Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes, EMBO J. 1989 Feb;8(2):429-33.
• 1988
  Mattei MG, de Thé H, Mattei JF, Marchio A, Tiollais P, Dejean A, Assignment of the human hap retinoic acid receptor RAR beta gene to the p24 band of chromosome 3, Hum. Genet. 1988 Oct;80(2):189-90.
• 1988
  Brand N, Petkovich M, Krust A, Chambon P, de Thé H, Marchio A, Tiollais P, Dejean A, Identification of a second human retinoic acid receptor, Nature 1988 Apr;332(6167):850-3.
• 1987
  de Thé H, Marchio A, Tiollais P, Dejean A, A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma, Nature 1987 Dec 17-23;330(6149):667-70.
• 1986
  Dejean A, Bougueleret L, Grzeschik KH, Tiollais P, Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma, Nature 1986 Jul 3-9;322(6074):70-2.
• 1985
  Tiollais P, Pourcel C, Dejean A, The hepatitis B virus, Nature 1985 Oct 10-16;317(6037):489-95.
• 1984
  Dejean A, Sonigo P, Wain-Hobson S, Tiollais P, Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat, Proc. Natl. Acad. Sci. U.S.A. 1984 Sep;81(17):5350-4.
• 1984
  Dejean A, Lugassy C, Zafrani S, Tiollais P, Brechot C, Detection of hepatitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus, J. Gen. Virol. 1984 Mar;65 ( Pt 3):651-5.
• 1983
  Dejean A, Brechot C, Tiollais P, Wain-Hobson S, Characterization of integrated hepatitis B viral DNA cloned from a human hepatoma and the hepatoma-derived cell line PLC/PRF/5, Proc. Natl. Acad. Sci. U.S.A. 1983 May;80(9):2505-9.
• 1982
  Dejean A, Vitvitski L, Brechot C, Trepo C, Tiollais P, Charnay P, Presence and state of woodchuck hepatitis virus DNA in liver and serum of woodchucks: further analogies with human hepatitis B virus, Virology 1982 Aug;121(1):195-9.
• 1982
  Dejean A, Carloni G, Bréchot C, Tiollais P, Wain-Hobson S, Organization and expression of hepatitis B sequences cloned from hepatocellular carcinoma tissue DNA, J. Cell. Biochem. 1982;20(3):293-301.
• 1981
  Bréchot C, Hadchouel M, Scotto J, Fonck M, Potet F, Vyas GN, Tiollais P, State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases, Proc. Natl. Acad. Sci. U.S.A. 1981 Jun;78(6):3906-10.